[Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy].

M D Ardatskaya L I Butorova M A Kalashnikova N R Nugaeva Y V Ovchinnikov O Sh Oynotkinova A I Pavlov Roman Plavnik E V Sayutina T B Topchiy S N Trunova

Published in: Terapevticheskii arkhiv (2021)

In mild cases, to reduce the severity of viral intestinal damage, for effective relief of intestinal symptoms, to reduce the risk of IBS-like symptoms, it is advisable to prescribe (Zacofalk) in an initial dose of 3 tablets per day.

Keyphrases

sars cov
coronavirus disease
sleep quality
oxidative stress
stem cells
mesenchymal stem cells
bone marrow
replacement therapy